Posted On: 03/08/2016 11:10:08 AM
Post# of 72446
Excerpt from an article about the Psoriasis drug referenced in Cellceutix's Facebook post. It was a POC with only 15 patients so the fact that one of 15 suffered a stroke (loss of blood flow to the brain) TIA may be a serious problem to watch.
"Researchers reported one serious adverse event that was possibly related to treatment, according to Skin and Allergy News; a transient ischemic attack experienced by one patient. Transient ischemic attacks, or TIAs, are often referred to as a “mini-stroke.”
https://www.psoriasis.org/advance/one-dose-of...for-a-year
Cellceutix believes Prurisol will show similar results but with better safety and orally administered. IMHO
"Researchers reported one serious adverse event that was possibly related to treatment, according to Skin and Allergy News; a transient ischemic attack experienced by one patient. Transient ischemic attacks, or TIAs, are often referred to as a “mini-stroke.”
https://www.psoriasis.org/advance/one-dose-of...for-a-year
Cellceutix believes Prurisol will show similar results but with better safety and orally administered. IMHO
(1)
(0)
